Idorsia aims to be Europe’s leading biopharmaceutical company, with a strong scientific core. We provide regular updates on the progress being made towards this goal. This section of the website provides journalists with additional material to support the generation of articles.


Event When

Citi BioPharma Conference

September 6-7, 2023

Morgan Stanley Global Healthcare Conference

September 11-14, 2023

Bank of America Global Healthcare Conference

September 13-14, 2023

Baader Investment Conference

September 18-22, 2023

Nine-Months 2023 Financial Results reporting*

October 24, 2023

Jefferies London Healthcare Conference

November 14-16, 2023

Credit Suisse Equity Forum Switzerland

November 14-16, 2023

Full-Year 2023 Financial Results reporting*

February 6, 2024

First Quarter 2024 Financial Results reporting*

April 25, 2024

*We will be in a silent period for 10 days ahead of the financial reporting.

Stay informed

Idorsia offers an electronic ‘Stay Informed’ service where subscribers can automatically receive updates via e-mail or SMS alert.

Stay informed

Social Media

Idorsia is active on social media – follow our channels to get a more personal view on the company.

Social Media

Media center

Idorsia provides images, fact sheets and B-roll to download or support you with your article.

Media center



Andrew C. Weiss

Senior Vice President, Head of Investor Relations and Corporate Communications

Media Relations

Resources in German

Als schweizerisches Unternehmen stellen wir interessierten Personen auf dieser Seite wesentliche Informationen über unser Unternehmen in deutscher Sprache zur Verfügung.